Figure 1.
Axillary lymph nodes management in breast cancer patients US: ultrasound; FNA: fine needle aspiration; SLN: sentinel lymph node; ITC: isolated tumour cells.
Table 1.
Clinical and histopathological characteristics of 1287 breast cancer patients who underwent axillary US examination.
Table 2.
Metastatic involvement of the axilla in 154 breast cancer patients that underwent US-guided FNA.
Table 3.
Relationship between US of the axilla with a suspect result, not confirmed by FNA and metastases in SLN.
Figure 2.
Number of axillary metastatic lymph nodes in breast cancer patients with positive (micro- and macrometastases) sentinel lymph nodes (SLNs) and in patients with positive ultrasound (US) guided fine needle aspiration cytology (FNA).
The percentage of cases with >3 axillary metastatic lymph nodes is higher in patients with positive US-guided FNA cytology than in patients with metastatic SLNs.
Table 4.
Status of axillary lymph nodes in 365 breast cancer patients with positive US-guided FNA or positive SLN.
Table 5.
Clinical and histological characteristics of patients stratified on the basis of axillary US-guided FNA results.